LRRK2 Phosphorylation, More Than an Epiphenomenon

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Mutations in the Leucine Rich Repeat Kinase 2 (LRRK2) gene are a known cause of autosomal dominant Parkinson's disease (PD).
• Genetic variations in the LRRK2 gene are also associated with an increased risk for developing sporadic PD.
• LRRK2 is a kinase that undergoes multiphosphorylation, crucial for its physiological and pathological functions.

Purpose of the Study:

• To review current knowledge on Leucine Rich Repeat Kinase 2 (LRRK2) phosphorylation.
• To discuss the regulatory mechanisms governing LRRK2 phosphorylation levels.
• To explore how alterations in LRRK2 phosphorylation affect cellular processes implicated in Parkinson's disease.

Main Methods:

• Literature review of existing research on LRRK2 phosphorylation.
• Analysis of evidence linking LRRK2 phosphorylation status to PD pathology.
• Synthesis of information on LRRK2 phosphoregulation and its cellular consequences.

Main Results:

• Reduced LRRK2 heterologous phosphorylation is observed in PD brains and upon pharmacological LRRK2 inhibition.
• Dephosphorylation of LRRK2 at heterologous phosphosites leads to its accumulation in subcellular compartments.
• The precise regulatory mechanisms and full cellular consequences of LRRK2 phosphorylation changes are not yet fully understood.

Conclusions:

• LRRK2 phosphorylation plays a critical role in both the normal function and the disease mechanisms of Parkinson's disease.
• Further research into LRRK2 phosphoregulation is necessary to fully elucidate its connection to PD.
• Understanding LRRK2 phosphorylation dynamics may reveal novel therapeutic targets for Parkinson's disease.